比如这个生物科技公司$迪卡斯(DCTH)$
相比IPO的时候缩骨了310亿倍
复权回去曾经的一股值5000亿刀
开眼界哈哈
—————
We have a history of reverse splits, which have severely impacted our common stock price.
Since our initi...查看全文
投资者阿登2023-08-16 15:28
迪卡斯(DCTH)盘前暴涨80%,报5.65美元。
美国食品和药物管理局(FDA)批准HEPZATO KIT(melphalan/Hepatic Delivery System)作为肝脏定向治疗,用于成人患者的转移性葡萄膜黑色素瘤,其不可切除的肝脏转移影响不到50%的肝脏,并且没有仅限于可切除或辐射的骨骼、淋巴结、皮下组织或肺的肝外疾病...查看全文
chuminhua2023-08-16 11:30
8/15,在 FDA 批准 Delcath Systems $迪卡斯(DCTH)$ 公司的 Hepzato用于治疗某些已扩散到肝脏的转移性葡萄膜黑色素瘤的成人患者后,该公司的股价上涨了 117% 以上。 该药将化疗药物melphalan与 Delcath 的肝脏输送系统相结合,旨在允许在靶组织中更高的药物暴露量,同时限制全身毒性。
具体来...查看全文
长红通通2023-08-15 22:58
$迪卡斯(DCTH)$ 美股发布当天发布利好当天大涨,A股当天发布利好叫利好出净,提前埋伏的资金大量出货。至于为什么有那么一些未卜先知的神秘资金提前进入利好还没发布的个股,这只能说这是大A的特色咯!查看全文
产业链观察2023-08-15 17:11
#药闻简讯# 2023年8月14日,$迪卡斯(DCTH)$ 今天宣布美国食品和药物管理局(FDA)批准HEPZATO KIT(美法仑/肝脏给药系统)作为肝脏导向疗法,用于治疗肝脏转移影响小于50%且无肝外疾病的不可切除肝转移性葡萄膜黑色素瘤(mUM)成人患者、或肝外病变局限于骨、淋巴结、皮下组织或肺部,可进行切除或...查看全文
$迪卡斯(DCTH)$ PRE 14A - Other preliminary proxy statements Filed: 2017-07-12 AccNo: 0001193125-17-226998 Size: 249 KB 网页链接
$迪卡斯(DCTH)$ 8-K/A [Amend] - Current report Filed: 2017-07-12 AccNo: 0001193125-17-226547 Size: 274 KBItem 1.01: Entry into a Material Definitive AgreementItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and ...
$迪卡斯(DCTH)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2017-07-06 AccNo: 0001193125-17-222865 Size: 310 KB 网页链接
$迪卡斯(DCTH)$ 8-K - Current report Filed: 2017-07-06 AccNo: 0001193125-17-222480 Size: 438 KBItem 1.01: Entry into a Material Definitive AgreementItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits h...
$迪卡斯(DCTH)$ 8-K - Current report Filed: 2017-07-06 AccNo: 0001193125-17-222480 Size: 438 KBItem 1.01: Entry into a Material Definitive AgreementItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits h...
$迪卡斯(DCTH)$ 8-K - Current report Filed: 2017-07-03 AccNo: 0001193125-17-220695 Size: 120 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal ...
$迪卡斯(DCTH)$ CORRESP [Cover] - Correspondence Filed: 2017-04-26 AccNo: 0001193125-17-137783 Size: 182 KB 网页链接
$迪卡斯(DCTH)$ UPLOAD [Cover] - SEC-generated letter Filed: 2017-05-05 AccNo: 0000000000-17-015833 Size: 68 KB 网页链接
$迪卡斯(DCTH)$ 8-K - Current report Filed: 2017-06-16 AccNo: 0001193125-17-206109 Size: 29 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$迪卡斯(DCTH)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-06-06 AccNo: 0001193125-17-195035 Size: 21 KB 网页链接